Anthony Beardsworth

1.9k total citations · 1 hit paper
20 papers, 1.5k citations indexed

About

Anthony Beardsworth is a scholar working on Clinical Psychology, Pulmonary and Respiratory Medicine and Psychiatry and Mental health. According to data from OpenAlex, Anthony Beardsworth has authored 20 papers receiving a total of 1.5k indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Clinical Psychology, 9 papers in Pulmonary and Respiratory Medicine and 9 papers in Psychiatry and Mental health. Recurrent topics in Anthony Beardsworth's work include Pulmonary Hypertension Research and Treatments (9 papers), Sexual function and dysfunction studies (9 papers) and Sexuality, Behavior, and Technology (9 papers). Anthony Beardsworth is often cited by papers focused on Pulmonary Hypertension Research and Treatments (9 papers), Sexual function and dysfunction studies (9 papers) and Sexuality, Behavior, and Technology (9 papers). Anthony Beardsworth collaborates with scholars based in United States, United Kingdom and Italy. Anthony Beardsworth's co-authors include Melanie Chan, Hossein Ardeschir Ghofrani, Nazzareno Galiè, Bruce H. Brundage, Robyn J. Barst, Shelley Shapiro, Gérald Simonneau, R. James White, Zeenat Safdar and Lyn R. Frumkin and has published in prestigious journals such as Circulation, Journal of the American College of Cardiology and CHEST Journal.

In The Last Decade

Anthony Beardsworth

20 papers receiving 1.4k citations

Hit Papers

Tadalafil Therapy for Pulmonary Arterial Hypertension 2009 2026 2014 2020 2009 250 500 750
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Tadalafil Therapy for Pulmonary Arterial Hypertension
    2009 794 citations Nazzareno Galiè, Bruce H. Brundage et al. Circulation profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Anthony Beardsworth United States 16 1.0k 737 315 227 203 20 1.5k
Melanie Chan United States 12 853 0.8× 630 0.9× 224 0.7× 188 0.8× 454 2.2× 19 1.5k
Hunter Gillies United States 19 1.4k 1.4× 865 1.2× 102 0.3× 224 1.0× 124 0.6× 42 1.9k
Timothy M. Costigan United States 16 111 0.1× 658 0.9× 583 1.9× 39 0.2× 505 2.5× 27 1.5k
Donald L. Akers United States 14 282 0.3× 242 0.3× 121 0.4× 12 0.1× 126 0.6× 33 766
Emma Dunn United Kingdom 12 272 0.3× 128 0.2× 22 0.1× 38 0.2× 205 1.0× 20 693
Zekeriya Nurkalem Türkiye 15 124 0.1× 396 0.5× 120 0.4× 13 0.1× 162 0.8× 59 681
Noreen A. Lemak United States 16 361 0.4× 450 0.6× 29 0.1× 20 0.1× 28 0.1× 26 1.3k
Robert Wake United States 20 632 0.6× 74 0.1× 66 0.2× 5 0.0× 146 0.7× 45 1.1k
Lukas Makris United States 15 208 0.2× 454 0.6× 69 0.2× 11 0.0× 169 0.8× 64 1.0k
Mohamedtaki Abdulaziz Tejani United States 22 454 0.5× 57 0.1× 53 0.2× 27 0.1× 13 0.1× 80 1.7k

Countries citing papers authored by Anthony Beardsworth

Since Specialization
Citations

This map shows the geographic impact of Anthony Beardsworth's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Anthony Beardsworth with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Anthony Beardsworth more than expected).

Fields of papers citing papers by Anthony Beardsworth

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Anthony Beardsworth. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Anthony Beardsworth. The network helps show where Anthony Beardsworth may publish in the future.

Co-authorship network of co-authors of Anthony Beardsworth

This figure shows the co-authorship network connecting the top 25 collaborators of Anthony Beardsworth. A scholar is included among the top collaborators of Anthony Beardsworth based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Anthony Beardsworth. Anthony Beardsworth is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Oudiz, Ronald J., Bruce H. Brundage, Nazzareno Galiè, et al.. (2012). Tadalafil for the Treatment of Pulmonary Arterial Hypertension. Journal of the American College of Cardiology. 60(8). 768–774. 103 indexed citations
2.
Paduch, Darius A., Alexander Bolyakov, Anthony Beardsworth, & Steven Watts. (2011). Factors associated with ejaculatory and orgasmic dysfunction in men with erectile dysfunction: analysis of clinical trials involving the phosphodiesterase type 5 inhibitor tadalafil. British Journal of Urology. 109(7). 1060–1067. 15 indexed citations
3.
Barst, Robyn J., Ronald J. Oudiz, Anthony Beardsworth, et al.. (2011). Tadalafil monotherapy and as add-on to background bosentan in patients with pulmonary arterial hypertension. The Journal of Heart and Lung Transplantation. 30(6). 632–643. 84 indexed citations
4.
Edgell, E.T., et al.. (2010). Treatment patterns and resource utilization and costs among patients with pulmonary arterial hypertension in the United States. Journal of Medical Economics. 13(3). 393–402. 40 indexed citations
5.
Galiè, Nazzareno, Bruce H. Brundage, Hossein Ardeschir Ghofrani, et al.. (2009). Tadalafil Therapy for Pulmonary Arterial Hypertension. Circulation. 119(22). 2894–2903. 794 indexed citations breakdown →
6.
Nakazawa, Takahiro, et al.. (2009). Tadalafil, a Long-Acting Inhibitor of PDE5, Improves Pulmonary Hemodynamics and Survival Rate of Monocrotaline-Induced Pulmonary Artery Hypertension in Rats. Journal of Pharmacological Sciences. 111(3). 235–243. 43 indexed citations
7.
Pepke‐Żaba, Joanna, et al.. (2009). Tadalafil therapy and health-related quality of life in pulmonary arterial hypertension. Current Medical Research and Opinion. 25(10). 2479–2485. 36 indexed citations
8.
9.
Cardozo, Linda, Rainer Lange, Simon Voss, et al.. (2009). Short- and long-term efficacy and safety of duloxetine in women with predominant stress urinary incontinence. Current Medical Research and Opinion. 26(2). 253–261. 19 indexed citations
10.
Beardsworth, Anthony, et al.. (2009). Blinded, Long-Term Safety and Efficacy of Tadalafil in Treatment for Pulmonary Arterial Hypertension.. A1042–A1042. 3 indexed citations
11.
Bump, Richard C., Simon Voss, Anthony Beardsworth, et al.. (2008). Long‐term efficacy of duloxetine in women with stress urinary incontinence. British Journal of Urology. 102(2). 214–218. 26 indexed citations
12.
Barst, Robyn J., Bruce H. Brundage, Hossein Ardeschir Ghofrani, et al.. (2008). TADALAFIL IMPROVES EXERCISE CAPACITY, HEALTH RELATED QUALITY OF LIFE AND DELAYS TIME TO CLINICAL WORSENING IN PATIENTS WITH SYMPTOMATIC PULMONARY ARTERIAL HYPERTENSION (PAH). CHEST Journal. 134(4). 39S–39S. 2 indexed citations
13.
Hatzichristou, Dimitrios, Josep María Haro, Antonio Martín‐Morales, et al.. (2007). Patterns of switching phosphodiesterase type 5 inhibitors in the treatment of erectile dysfunction: results from the Erectile Dysfunction Observational Study. International Journal of Clinical Practice. 61(11). 1850–1862. 22 indexed citations
14.
15.
16.
Martín‐Morales, Antonio, Josep María Haro, Anthony Beardsworth, Jordan Bertsch, & Stathis Kontodimas. (2006). Therapeutic Effectiveness and Patient Satisfaction after 6 Months of Treatment with Tadalafil, Sildenafil, and Vardenafil: Results from the Erectile Dysfunction Observational Study (EDOS). European Urology. 51(2). 541–550. 46 indexed citations
17.
18.
Haro, Josep María, Anthony Beardsworth, Sandra Gavart, et al.. (2006). Treatment-Seeking Behavior of Erectile Dysfunction Patients in Europe: Results of the Erectile Dysfunction Observational Study. The Journal of Sexual Medicine. 3(3). 530–540. 32 indexed citations
19.
Eardley, Ian, Vincenzo Mirone, Francesco Montorsi, et al.. (2005). An open‐label, multicentre, randomized, crossover study comparing sildenafil citrate and tadalafil for treating erectile dysfunction in men naïve to phosphodiesterase 5 inhibitor therapy. British Journal of Urology. 96(9). 1323–1332. 70 indexed citations
20.
Eardley, Ian, et al.. (2004). Efficacy and safety of tadalafil in a Western European population of men with erectile dysfunction. British Journal of Urology. 94(6). 871–877. 38 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Melanie Chan Breakdown of academic impact, for papers by Hunter Gillies Breakdown of academic impact, for papers by Timothy M. Costigan Breakdown of academic impact, for papers by Donald L. Akers Breakdown of academic impact, for papers by Emma Dunn Breakdown of academic impact, for papers by Zekeriya Nurkalem Breakdown of academic impact, for papers by Noreen A. Lemak Breakdown of academic impact, for papers by Robert Wake Breakdown of academic impact, for papers by Lukas Makris Breakdown of academic impact, for papers by Mohamedtaki Abdulaziz Tejani
Rankless by CCL
2026